APERÇU CARTOGRAPHIQUE
| ESSAI CLINIQUE | INSTITUTION | TRAITEMENT OFFERT |
|---|---|---|
|
(EN) A Multicenter, Open Label, Non-randomized First-in-human Phase 1 Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of BAY 3547926 Alone, and in Combination, in Participants With Advanced Hepatocellular Carcinoma (HCC)
BANTAM-01 Actif en recrutement |
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE HOPITAL FLEURIMONT |
|